Another parameter that may have an important place in clinical practice and which may be significant in terms of real-life data is the other bleeding that does not meet the major bleeding criteria.
← all excerpts
Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data.
1
—
—